Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Insulin Sensitivity in Rheumatoid Arthritis
NCT01132118Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydroxychloroquine in insulin resistance (IR), sponsored by Brigham and Women's Hospital. Started Jun 2010; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT01132118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132118.